https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53520 28.4 ng/mL) was independently associated with older age, use of beta-blockers, and number of MACE events within a 1 year period. In this patient cohort, elevated sST2 levels are associated with unplanned hospital admission due to MACE within 1 year, independent of the nature of the index cardiovascular admission.]]> Wed 28 Feb 2024 15:31:59 AEDT ]]> Suboptimal Use of Cardioprotective Medications in Patients With a History of Cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42651 Wed 01 Mar 2023 15:00:54 AEDT ]]> Overexpression of Mitochondrial Catalase within Adipose Tissue Does Not Confer Systemic Metabolic Protection against Diet-Induced Obesity https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52575 Tue 17 Oct 2023 15:48:02 AEDT ]]> Sex-based differences in short- and longer-term diet-induced metabolic heart disease https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55437 Thu 30 May 2024 14:32:42 AEST ]]> Association of Circulating Plasma Secreted Frizzled-Related Protein 5 (Sfrp5) Levels with Cardiac Function https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52280 Mon 09 Oct 2023 10:02:50 AEDT ]]> Heart Failure in Breast Cancer Survivors: Focus on Early Detection and Novel Biomarkers https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48913 Fri 14 Apr 2023 18:21:40 AEST ]]>